Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets express concern over cheap wormer promotion
"It is exceedingly disappointing to see de-wormers being advertised in this way" - David Rendle, BEVA.
Retailer accused of putting 'short-term profits above equine welfare'.

The British Equine Veterinary Association (BEVA) has expressed concern over a ‘potentially damaging’ online promotion advertising cheap wormers for horses.

The well-known retailer advertised 'horse wormers from £4.33', and the Association fears this could lead horse owners to make poor judgments on equine worm management based primarily on cost rather than clinical need. 

The subject has been the subject of debate in the equine press, with Horse & Hound recently publishing an item featuring a statement from BEVA. 

"It is exceedingly disappointing to see de-wormers being advertised in this way by companies who are putting their short-term profits above equine welfare and the long-term effectiveness of these products,” commented David Rendle, chair of BEVA’s Health and Medicines Committee.

“We now have resistance to every class of de-wormer and it is grossly irresponsible to be promoting these products based on their low cost. These products should only be used where there has been careful consideration of the risk of clinical disease and appropriate diagnostic testing.

“Antibacterial drugs would never be advertised in this way, so why is it acceptable for de-wormers? Resistant worms pose a far more immediate threat to equine welfare than resistant bacteria.  Is the equine industry ever going to wake up to the threat that resistant parasites pose to equine welfare and the future viability of the industry?”

A spokesperson for the retailer expressed regret for the promotion's content and pledged to review the firm's communications to ensure appropriate guidance is provided.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
NSA webinar explores sheep tailing and castration

The National Sheep Association (NSA) is to host a free webinar on the castration and tail docking of lambs.

The webinar, 'Understanding the tailing and castration consultation: A guide for sheep farmers', will be hosted online on Monday, 2 March 2026 at 7.30pm.

It comes during a government consultation into the methods used for these procedures. Farmers are encouraged to engage before the consultation period closes on Monday, 9 March 2026.

The webinar offers clear and actionable guidance to support farmers to contribute meaningfully to the consultation and prepare for potential changes.

On the panel will be former SVS president Kate Hovers, farmer and vet Ann Van Eetvelt and SRUC professor in Animal Health and Veterinary Sciences Cathy Dwyer. Each panel member will utilise their own specialism and expertise to evaluate risks and outcomes to sheep farming.

Find out more about the webinar on the NSA website.